Variables | FDI group | EWI group | FDI + EWI group | Control group | P-value* |
---|---|---|---|---|---|
Age (year) | 46.68 ± 18.73 | 46.66 ± 19.53 | 48.12 ± 17.86 | 47.66 ± 18.09 | 0.97 |
 ≥ 35 years (%) | 70.0 | 68.0 | 80.0 | 74.0 | 0.54 |
Female (%) | 58.0 | 48.0 | 50.0 | 56.0 | 0.64 |
Married (%) | 62.0 | 74.0 | 68.0 | 70.0 | 0.62 |
Having health insurance (%) | 94.0 | 94.0 | 94.0 | 92.0 | 0.97 |
Occupation (jobless) (%) | 34.0 | 36.0 | 46.0 | 30.0 | 0.39 |
Economic status (weak) (%) | 22.0 | 38.0 | 40.0 | 42.0 | 0.40 |
Cancer diagnosis time (< 6 months) | 12.0 | 18.0 | 12.0 | 26.0 | 0.69 |
Cancer therapy | 0.79 | ||||
 Chemotherapy (%) | 54.0 | 52.0 | 52.0 | 58.0 |  |
 Radiotherapy (%) | 6.0 | 8.0 | 12.0 | 14.0 |  |
Operation history (%) | 58.0 | 58.0 | 62.0 | 52.0 | 0.79 |
Disease stage (stage 4) (%) | 38.0 | 46.0 | 46.0 | 42.0 | 0.80 |
Cancer type (%) | 0.43 | ||||
 Lung | 4.0 | 8.0 | 6.0 | 10.0 |  |
 Colorectal | 16.0 | 12.0 | 22.0 | 14.0 |  |
 Breast | 16.0 | 8.0 | 6.0 | 4.0 |  |
 Leukemia | 8.0 | 6.0 | 10.0 | 12.0 |  |
 Gastric | 6.0 | 8.0 | 4.0 | 10.0 |  |
 Liver | 8.0 | 6.0 | 4.0 | 4.0 |  |
 Pancreases | 2.0 | 4.0 | 10.0 | 10.0 |  |
 Ovarian | 4.0 | 6.0 | 4.0 | 4.0 |  |
 Prostate | 2.0 | 6.0 | 6.0 | 2.0 |  |
 Sarcoma | 18.0 | 22.0 | 14.0 | 14.0 |  |
 Esophageal | 8.0 | 6.0 | 4.0 | 4.0 |  |
 Brain | 4.0 | 2.0 | 0 | 2.0 |  |
 Bladder | 2.0 | 0 | 2.0 | 10.0 |  |
 Lymphoma | 2.0 | 4.0 | 8.0 | 0 |  |